These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15249860)

  • 1. Basal cell carcinoma with sebaceous differentiation.
    Misago N; Suse T; Uemura T; Narisawa Y
    Am J Dermatopathol; 2004 Aug; 26(4):298-303. PubMed ID: 15249860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sebaceous carcinoma with apocrine differentiation.
    Misago N; Narisawa Y
    Am J Dermatopathol; 2001 Feb; 23(1):50-7. PubMed ID: 11176053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sebaceous neoplasms in Siriraj Hospital, Mahidol University: a 9-year-retrospective study.
    Manonukul J; Kajornvuthidej S
    J Med Assoc Thai; 2010 Aug; 93(8):978-91. PubMed ID: 20718175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cornification (keratinization) in Basal cell carcinoma: a histopathological and immunohistochemical study of 16 cases.
    Misago N; Satoh T; Narisawa Y
    J Dermatol; 2004 Aug; 31(8):637-50. PubMed ID: 15492437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sebaceous carcinoma: an immunohistochemical reappraisal.
    Ansai S; Takeichi H; Arase S; Kawana S; Kimura T
    Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic Mimics of Basal Cell Carcinoma.
    Stanoszek LM; Wang GY; Harms PW
    Arch Pathol Lab Med; 2017 Nov; 141(11):1490-1502. PubMed ID: 29072946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rippled-pattern basal cell carcinoma.
    Misago N; Tsuruta N; Narisawa Y
    J Dermatol; 2012 Jul; 39(7):632-5. PubMed ID: 22211777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sebaceoma and related neoplasms with sebaceous differentiation: a clinicopathologic study of 30 cases.
    Misago N; Mihara I; Ansai S; Narisawa Y
    Am J Dermatopathol; 2002 Aug; 24(4):294-304. PubMed ID: 12142607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
    Yang HM; Cabral E; Dadras SS; Cassarino DS
    Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
    Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
    Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
    Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid synthesis and processing proteins ABHD5, PGRMC1 and squalene synthase can serve as novel immunohistochemical markers for sebaceous neoplasms and differentiate sebaceous carcinoma from sebaceoma and basal cell carcinoma with clear cell features.
    Chen WS; Chen PL; Li J; Lind AC; Lu D
    J Cutan Pathol; 2013 Jul; 40(7):631-8. PubMed ID: 23557589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sebaceous carcinoma of the eyelids: thirty cases from Japan.
    Izumi M; Mukai K; Nagai T; Matsubayashi J; Iwaya K; Chiu CS; Goto H
    Pathol Int; 2008 Aug; 58(8):483-8. PubMed ID: 18705767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
    Mittal R; Araujo I; Czanner G; Coupland SE
    Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collision sebaceous and basal cell carcinomas of the eyelid.
    Levy J; Cagnano E; Benharroch D; Monos T; Lifshitz T
    Ann Diagn Pathol; 2006 Jun; 10(3):157-9. PubMed ID: 16730311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma.
    Sinard JH
    Arch Ophthalmol; 1999 Jun; 117(6):776-83. PubMed ID: 10369589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sebaceous carcinoma within rippled/carcinoid pattern sebaceoma.
    Misago N; Toda S
    J Cutan Pathol; 2016 Jan; 43(1):64-70. PubMed ID: 26268140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentially actionable FGFR2 high-level amplification in thymic sebaceous carcinoma.
    Porubsky S; Jessup P; Kee D; Sharma R; Ochi A; Xu H; Froelich JJ; Nott L; Scott C; Awad R; Moldovan C; Hardikar AA; Bohnenberger H; Küffer S; Ströbel P; Marx A
    Virchows Arch; 2020 Feb; 476(2):323-327. PubMed ID: 31401665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basaloid neoplasms in nevus sebaceus.
    Kaddu S; Schaeppi H; Kerl H; Soyer HP
    J Cutan Pathol; 2000 Aug; 27(7):327-37. PubMed ID: 10917159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periocular Sebaceous Carcinoma With Apocrine Differentiation: A Case Report and Review of the Literature.
    Pinheiro JAF; Lopes JMPB
    Int J Surg Pathol; 2019 Jun; 27(4):432-436. PubMed ID: 30522363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.